Skip to main content
Log in

The antiadrenergic effect of neuropeptide Y on the ventricular cardiomyocyte

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The effect of neuropeptide Y (NPY) on adenylate cyclase activity was examined in ventricular myocytes isolated from the adult rat heart. In the presence of the phosphodiesterase inhibitor Ro 20-1724 (0.5 mM) and adenosine deaminase (5 U/ml), these intact cells accumulate cyclic AMP when stimulated by isoproterenol. NPY (10−9 to 10−6 M) reduced the degree of cAMP accumulation achieved by 10−7 M isoproterenol in a dose dependend manner by 10 to maximally 48%. The IC 50 value was 3 x 10−8 M NPY. A maximal concentration (10−6 M) of N6-phenylisopropyladenosine (PIA) decreased cAMP levels by 39%, i.e. to a similar extent. Prior treatment of the myocytes with pertussis toxin (1 μg/ml for 6 h) increased the mean stimulated values in the presence of isoproterenol (10−7 M) by a factor 4.1. In such cells, NPY and PIA were ineffective in antagonizing the stimulation of cAMP production by isoproterenol. These results indicate that the ventricular myocyte has receptors for NPY, similar to the A1 adenosinereceptor in that they are linked to the adenylate cyclase by an inhibitory guanylate binding protein.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

NPY:

neuropeptide Y

PIA:

N6-phenylisopropyl-adenosine

Ro 20-1724:

4-(3-butoxy-4-ethoxybenzyl)-2-imidazolidione

Hepes:

4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid

References

  • Allen JM, Adrian TE, Tatemoto K, Polak JM, Hughes J, Bloom SR (1982) Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens. Neuropeptides 3:71–77

    Google Scholar 

  • Allen JM, Bircham PMM, Edwards AV, Tatemoto K, Loom SR (1983) Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart. Regulat Peptides 6:247–253

    Google Scholar 

  • Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248–254

    Article  CAS  PubMed  Google Scholar 

  • Edvinsson L, Hakanson R, Wahlestedt C, Uddman R (1987) Effects of neuropeptide Y on the cardiovascular system. Trends Pharmacol Sci 8:231–235

    Google Scholar 

  • Goldman SJ, Dickinson ES, Slakey LL (1983) Effect of adenosine on synthesis and release of cyclic AMP by cultured vascular cells from swine. J Cyclic Nucleotide Prot Phosphor Res 9: 69–78

    Google Scholar 

  • Hassall CJS, Burnstock G (1984) Neuropeptide Y-like immunoreactivity in cultured intrinsic neurones of the heart. Neurosci Lett 52:111–115

    Google Scholar 

  • Henrich M, Piper HM, Schrader J (1987) Evidence for cyclase coupled A1-adenosine receptors on ventricular cardiomyocytes from adult rat and dog heart. Life Sci 41:2381–2388

    Google Scholar 

  • Kassis S, Olasmaa M, Terenius L, Fishman PH (1987) Neuropeptide Y inhibits cardiac adenylate cyclase through a pertussis toxinsensitive G protein. J Biol Chem 262:3429–3431

    Google Scholar 

  • Kroll K, Schrader J, Piper HM, Henrich M (1987) Release of adenosine and cyclic AMP from coronary endothelium in isolated guinea pig hearts: relation to coronary flow. Circ Res 60:659–665

    Google Scholar 

  • Martens G, Lohse MJ, Rauch B, Schwabe U (1987) Pharmacological characterization of A1 adenosine receptors in isolated rat ventricular myocytes. Naunyn-Schmiedeberg's Arch Pharmacol 336:342–348

    Google Scholar 

  • Piper HM, Probst I, Schwartz P, Hütter JF, Spieckermann PG (1982) Culturing of calcium stable adult cardiac myocytes. J Mol Cell Cardiol 14:397–412

    Google Scholar 

  • Rioux F, Bachelard H, Martel JC, St-Pierre S (1986) The vasoconstrictor effect of neuropeptide Y and related peptide in the guinea pig isolated heart. Peptides 7:27–31

    Google Scholar 

  • Ui M (1984) Islet-activating protein, pertussis toxin: a probe for functions of the inhibitory guanine nucleotide regulatory components of adenylate cyclase. Trends Pharmacol Sci 5:277–279

    Google Scholar 

  • Wahlestedt C, Wohlfart B, Hakanson R (1987) Effects of neuropeptide Y (NPY) on isolated guinea-pig heart. Acta Physiol Scand 129:459–463

    Google Scholar 

  • Westlind-Danielson A, Unden A, Abens J, Andell S, Bartfai T (1987) Neuropeptide Y receptors and inhibition of adenylate cyclase in the human frontal and temporal cortex. Neurosci Lett 74:237–242

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Send offprint requests to H. M. Piper at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Millar, B., Piper, H.M. & McDermott, B.J. The antiadrenergic effect of neuropeptide Y on the ventricular cardiomyocyte. Naunyn-Schmiedeberg's Arch Pharmacol 338, 426–429 (1988). https://doi.org/10.1007/BF00172122

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00172122

Key words

Navigation